Pulmonary toxicity of instilled cadmium-doped silica nanoparticles during acute and subacute stages in rats

Teresa Coccini, Sergio Barni, Rita Vaccarone, Piercarlo Mustarelli, Luigi Manzo, Elisa Roda

Research output: Contribution to journalArticle

Abstract

Potential risk associated with new nanomaterial exposure needs to be assessed. This in vivo study investigated pulmonary effects of engineered cadmium-containing silica nanoparticles Cd/SiNPs (1 mg/rat), silica SiNPs (600 μg/rat) and CdCl2 (400 μg/rat) 1, 7 and 30 days after intratracheal instillation. Comprehensive histopathological and immunocytochemical characterization of lung damage in terms of apoptosis, cell proliferation, inflammation, fibrosis and metabolism were obtained. After exposure to all treatments, lung parenchyma showed injury patterns characterized by collapsed alveoli, inflammation, granuloma formation, thickened alveolar septa and bronchiolar epithelium exfoliation. Type II pneumocytes, containing scarcely surfactantlamellated bodies, were also observed. Apoptotic phenomena enhanced as following, Cd/SiNPs>CdCl2> SiNPs. In parallel with these findings, a significant increase of PCNA-immunoreactive cells was detected together with high mitotic activity. Cellular localization and distribution of IL-6, IP-10 and TGF-ß1 revealed an increased expression of these cytokines as evidence of an enhanced cellular inflammatory response. CYP450- immunoreactivity was also enhanced, at bronchiolar (e.g. Clara cells) and alveolar (e.g. macrophages) level after both Cd/SiNPs and CdCl2. These overall effects were observed acutely and lasted until the 30th day, with Cd/SiNPs producing the most marked effects. Collagen-immunolabelling changed particularly 7 and 30 days after Cd/SiNPs, when a strong stromal fibrogenic reaction occurred. The present findings suggest that Cd/SiNPs produce significantly greater pulmonary alterations than either SiNPs or CdCl2 under the present experimental conditions.

Original languageEnglish
Pages (from-to)195-209
Number of pages15
JournalHistology and Histopathology
Volume28
Issue number2
Publication statusPublished - Feb 2013

Fingerprint

Cadmium Chloride
Cadmium
Silicon Dioxide
Nanoparticles
Lung
Inflammation
Alveolar Epithelial Cells
Nanostructures
Alveolar Macrophages
Proliferating Cell Nuclear Antigen
Granuloma
Interleukin-6
Fibrosis
Collagen
Epithelium
Cell Proliferation
Apoptosis
Cytokines
Wounds and Injuries

Keywords

  • Apoptosis
  • Fibrosis
  • In vivo
  • Inflammation
  • Nanotoxicology

ASJC Scopus subject areas

  • Histology
  • Pathology and Forensic Medicine

Cite this

Pulmonary toxicity of instilled cadmium-doped silica nanoparticles during acute and subacute stages in rats. / Coccini, Teresa; Barni, Sergio; Vaccarone, Rita; Mustarelli, Piercarlo; Manzo, Luigi; Roda, Elisa.

In: Histology and Histopathology, Vol. 28, No. 2, 02.2013, p. 195-209.

Research output: Contribution to journalArticle

Coccini, T, Barni, S, Vaccarone, R, Mustarelli, P, Manzo, L & Roda, E 2013, 'Pulmonary toxicity of instilled cadmium-doped silica nanoparticles during acute and subacute stages in rats', Histology and Histopathology, vol. 28, no. 2, pp. 195-209.
Coccini, Teresa ; Barni, Sergio ; Vaccarone, Rita ; Mustarelli, Piercarlo ; Manzo, Luigi ; Roda, Elisa. / Pulmonary toxicity of instilled cadmium-doped silica nanoparticles during acute and subacute stages in rats. In: Histology and Histopathology. 2013 ; Vol. 28, No. 2. pp. 195-209.
@article{639f8c5292bb459899725172a81e60bf,
title = "Pulmonary toxicity of instilled cadmium-doped silica nanoparticles during acute and subacute stages in rats",
abstract = "Potential risk associated with new nanomaterial exposure needs to be assessed. This in vivo study investigated pulmonary effects of engineered cadmium-containing silica nanoparticles Cd/SiNPs (1 mg/rat), silica SiNPs (600 μg/rat) and CdCl2 (400 μg/rat) 1, 7 and 30 days after intratracheal instillation. Comprehensive histopathological and immunocytochemical characterization of lung damage in terms of apoptosis, cell proliferation, inflammation, fibrosis and metabolism were obtained. After exposure to all treatments, lung parenchyma showed injury patterns characterized by collapsed alveoli, inflammation, granuloma formation, thickened alveolar septa and bronchiolar epithelium exfoliation. Type II pneumocytes, containing scarcely surfactantlamellated bodies, were also observed. Apoptotic phenomena enhanced as following, Cd/SiNPs>CdCl2> SiNPs. In parallel with these findings, a significant increase of PCNA-immunoreactive cells was detected together with high mitotic activity. Cellular localization and distribution of IL-6, IP-10 and TGF-{\ss}1 revealed an increased expression of these cytokines as evidence of an enhanced cellular inflammatory response. CYP450- immunoreactivity was also enhanced, at bronchiolar (e.g. Clara cells) and alveolar (e.g. macrophages) level after both Cd/SiNPs and CdCl2. These overall effects were observed acutely and lasted until the 30th day, with Cd/SiNPs producing the most marked effects. Collagen-immunolabelling changed particularly 7 and 30 days after Cd/SiNPs, when a strong stromal fibrogenic reaction occurred. The present findings suggest that Cd/SiNPs produce significantly greater pulmonary alterations than either SiNPs or CdCl2 under the present experimental conditions.",
keywords = "Apoptosis, Fibrosis, In vivo, Inflammation, Nanotoxicology",
author = "Teresa Coccini and Sergio Barni and Rita Vaccarone and Piercarlo Mustarelli and Luigi Manzo and Elisa Roda",
year = "2013",
month = "2",
language = "English",
volume = "28",
pages = "195--209",
journal = "Histology and Histopathology",
issn = "0213-3911",
publisher = "Histology and Histopathology",
number = "2",

}

TY - JOUR

T1 - Pulmonary toxicity of instilled cadmium-doped silica nanoparticles during acute and subacute stages in rats

AU - Coccini, Teresa

AU - Barni, Sergio

AU - Vaccarone, Rita

AU - Mustarelli, Piercarlo

AU - Manzo, Luigi

AU - Roda, Elisa

PY - 2013/2

Y1 - 2013/2

N2 - Potential risk associated with new nanomaterial exposure needs to be assessed. This in vivo study investigated pulmonary effects of engineered cadmium-containing silica nanoparticles Cd/SiNPs (1 mg/rat), silica SiNPs (600 μg/rat) and CdCl2 (400 μg/rat) 1, 7 and 30 days after intratracheal instillation. Comprehensive histopathological and immunocytochemical characterization of lung damage in terms of apoptosis, cell proliferation, inflammation, fibrosis and metabolism were obtained. After exposure to all treatments, lung parenchyma showed injury patterns characterized by collapsed alveoli, inflammation, granuloma formation, thickened alveolar septa and bronchiolar epithelium exfoliation. Type II pneumocytes, containing scarcely surfactantlamellated bodies, were also observed. Apoptotic phenomena enhanced as following, Cd/SiNPs>CdCl2> SiNPs. In parallel with these findings, a significant increase of PCNA-immunoreactive cells was detected together with high mitotic activity. Cellular localization and distribution of IL-6, IP-10 and TGF-ß1 revealed an increased expression of these cytokines as evidence of an enhanced cellular inflammatory response. CYP450- immunoreactivity was also enhanced, at bronchiolar (e.g. Clara cells) and alveolar (e.g. macrophages) level after both Cd/SiNPs and CdCl2. These overall effects were observed acutely and lasted until the 30th day, with Cd/SiNPs producing the most marked effects. Collagen-immunolabelling changed particularly 7 and 30 days after Cd/SiNPs, when a strong stromal fibrogenic reaction occurred. The present findings suggest that Cd/SiNPs produce significantly greater pulmonary alterations than either SiNPs or CdCl2 under the present experimental conditions.

AB - Potential risk associated with new nanomaterial exposure needs to be assessed. This in vivo study investigated pulmonary effects of engineered cadmium-containing silica nanoparticles Cd/SiNPs (1 mg/rat), silica SiNPs (600 μg/rat) and CdCl2 (400 μg/rat) 1, 7 and 30 days after intratracheal instillation. Comprehensive histopathological and immunocytochemical characterization of lung damage in terms of apoptosis, cell proliferation, inflammation, fibrosis and metabolism were obtained. After exposure to all treatments, lung parenchyma showed injury patterns characterized by collapsed alveoli, inflammation, granuloma formation, thickened alveolar septa and bronchiolar epithelium exfoliation. Type II pneumocytes, containing scarcely surfactantlamellated bodies, were also observed. Apoptotic phenomena enhanced as following, Cd/SiNPs>CdCl2> SiNPs. In parallel with these findings, a significant increase of PCNA-immunoreactive cells was detected together with high mitotic activity. Cellular localization and distribution of IL-6, IP-10 and TGF-ß1 revealed an increased expression of these cytokines as evidence of an enhanced cellular inflammatory response. CYP450- immunoreactivity was also enhanced, at bronchiolar (e.g. Clara cells) and alveolar (e.g. macrophages) level after both Cd/SiNPs and CdCl2. These overall effects were observed acutely and lasted until the 30th day, with Cd/SiNPs producing the most marked effects. Collagen-immunolabelling changed particularly 7 and 30 days after Cd/SiNPs, when a strong stromal fibrogenic reaction occurred. The present findings suggest that Cd/SiNPs produce significantly greater pulmonary alterations than either SiNPs or CdCl2 under the present experimental conditions.

KW - Apoptosis

KW - Fibrosis

KW - In vivo

KW - Inflammation

KW - Nanotoxicology

UR - http://www.scopus.com/inward/record.url?scp=84873834189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873834189&partnerID=8YFLogxK

M3 - Article

C2 - 23275303

AN - SCOPUS:84873834189

VL - 28

SP - 195

EP - 209

JO - Histology and Histopathology

JF - Histology and Histopathology

SN - 0213-3911

IS - 2

ER -